OGI OrganiGram
- 1.7100
- 0.00000.00%
- 1.7200
- +0.0100+0.58%
OrganiGram News
Organigram And This Canadian Cannabis Brand Expand In Europe And Beyond
Germany's recent legislative push in the cannabis sector marks a significant turning point not only for the country but also for the European cannabis landscape.Europe has become more open-minded abou
Stocks in Play: Organigram Holdings Inc.
Organigram to Supply U.K.'s Avida Medical With Dried Cannabis Flower in Three-Year Deal
Organigram Holdings (NASDAQ and TSX: OGI), a licensed producer of cannabis, said Tuesday that it has signed a three-year supply agreement with Avida Medical, a full-service medical cannabis and specia
Organigram Signs Three Year Supply Agreement With Avida Medical in UK
Over a three-year period, Organigram expects to supply 1,700 kilograms of high-quality medical cannabis flower to Avida Medical, with 500 kilograms expected to be delivered in the first year of the agreement. Avida
Analysts' Top Healthcare Picks: OrganiGram Holdings (OGI), Plus Therapeutics (PSTV)
Organigram Holdings Inc Price Target Cut to C$4.35/Share From C$4.40 by Jefferies & Co
Organigram Holdings Inc Price Target Cut to C$4.35/Share From C$4.40 by Jefferies & Co
Cannabis Stock Gainers And Losers From May 16, 2024
GAINERS:Flower One Hldgs (OTC:FLOOF) shares closed up 900.00% at $1e-05Cannabix Technologies (OTC:BLOZF) shares closed up 28.41% at $0.60Greenlane Hldgs (NASDAQ:GNLN) shares closed up 16.06% at $0.61C
Organigram Holdings Inc. Price Target Cut to C$3.25/Share From C$3.75 by Canaccord Genuity
Organigram Holdings Inc. Price Target Cut to C$3.25/Share From C$3.75 by Canaccord Genuity
Earnings Call Summary | OrganiGram(OGI.US) Q2 2024 Earnings Conference
The following is a summary of the Organigram Holdings Inc. (OGI) Q2 2024 Earnings Call Transcript:Financial Performance:Organigram reported increased cash position due to $124.6 million investment fro
Toronto Stocks Edge Down; Hudbay Minerals Rises on 1Q Earnings Beat
Stocks listed in Toronto were slightly lower Tuesday. Sector performance was mixed, with gains primarily in process industries, consumer discretionary and materials offset by declines largely in utilities, industrial services and distribution services.
Organigram Fiscal Q2 Loss Surges as Revenue Falls 5%
Organigram Holdings (NASDAQ and TSX: OGI), a licensed producer of cannabis, on Tuesday reported a fiscal second-quarter net loss of $27.1 million, more than triple the loss of $7.5 million a year earl
OrganiGram: Fiscal Q2 Earnings Snapshot
OrganiGram | 6-K: Report of foreign private issuer (related to financial reporting)
Organigram Reports 262% Higher Quarterly Net Loss YoY, Makes Progress In International Markets
Canadian cannabis company Organigram Holdings Inc.(NASDAQ:OGI) (TSX:OGI) reported its financial results Tuesday for the second quarter that ended March 31, 2024, revealing net revenue of CA$37.63 mill
OrganiGram 2Q Loss Widens
By Adriano Marchese OrganiGram Holdings on Tuesday reported a wider loss in its second fiscal quarter on the back of fair-value changes on its balance sheet in the quarter. For the three months ende
Organigram's Strong Q2 Growth and Strategic Moves
Organigram Brief: Q2 Fiscal 2024 Net Loss Was $27.1 Million Compared to $7.5 Million in Q2 Fiscal 2023
06:14 AM EDT, 05/14/2024 (MT Newswires) -- Organigram Brief: Q2 Fiscal 2024 Net loss was $27.1 million compared to $7.5 million in Q2 Fiscal 2023
Express News | Organigram Q2 Fiscal 2024 Net Loss Was C$27.1M Compared To C$7.5M A Year Ago
Express News | OrganiGram Holdings Q2 Sales C$37.628M Miss C$38.025M Estimate
OrganiGram Holdings 2Q Rev $37.6M >OGI
OrganiGram Holdings 2Q Rev $37.6M >OGI
Analysis
Price Target
No Data
